Cargando…

Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes

Background: Endometriosis is a chronic, estrogen-dependent, inflammatory disease, whose pivotal symptoms are dysmenorrhea, dyspareunia, and chronic pelvic pain (CPP). Besides the usual medical treatments, recent evidence suggests there are potential benefits of oral N-acetylcysteine (NAC) on endomet...

Descripción completa

Detalles Bibliográficos
Autores principales: Anastasi, Emanuela, Scaramuzzino, Sara, Viscardi, Maria Federica, Viggiani, Valentina, Piccioni, Maria Grazia, Cacciamani, Laura, Merlino, Lucia, Angeloni, Antonio, Muzii, Ludovico, Porpora, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048621/
https://www.ncbi.nlm.nih.gov/pubmed/36981595
http://dx.doi.org/10.3390/ijerph20064686
_version_ 1785014241842954240
author Anastasi, Emanuela
Scaramuzzino, Sara
Viscardi, Maria Federica
Viggiani, Valentina
Piccioni, Maria Grazia
Cacciamani, Laura
Merlino, Lucia
Angeloni, Antonio
Muzii, Ludovico
Porpora, Maria Grazia
author_facet Anastasi, Emanuela
Scaramuzzino, Sara
Viscardi, Maria Federica
Viggiani, Valentina
Piccioni, Maria Grazia
Cacciamani, Laura
Merlino, Lucia
Angeloni, Antonio
Muzii, Ludovico
Porpora, Maria Grazia
author_sort Anastasi, Emanuela
collection PubMed
description Background: Endometriosis is a chronic, estrogen-dependent, inflammatory disease, whose pivotal symptoms are dysmenorrhea, dyspareunia, and chronic pelvic pain (CPP). Besides the usual medical treatments, recent evidence suggests there are potential benefits of oral N-acetylcysteine (NAC) on endometriotic lesions and pain. The primary objective of this prospective single-cohort study was to confirm the effectiveness of NAC in reducing endometriosis-related pain and the size of ovarian endometriomas. The secondary objective was to assess if NAC may play a role in improving fertility and reducing the Ca125 serum levels. Methods: Patients aged between 18–45 years old with a clinical/histological diagnosis of endometriosis and no current hormonal treatment or pregnancy were included in the study. All patients received quarterly oral NAC 600 mg, 3 tablets/day for 3 consecutive days of the week for 3 months. At baseline and after 3 months, dysmenorrhea, dyspareunia and CPP were assessed using the Visual Analog Scale score (VAS), while the size of the endometriomas was estimated through a transvaginal ultrasound. Analgesics (NSAIDs) intake, the serum levels of Ca125 and the desire for pregnancy were also investigated. Finally, the pregnancy rate of patients with reproductive desire was evaluated. Results: One hundred and twenty patients were recruited. The intensity of dysmenorrhea, dyspareunia and CPP significantly improved (p < 0.0001). The use of NSAIDs (p = 0.001), the size of the endometriomas (p < 0.0001) and the serum levels of Ca125 (p < 0.0001) significantly decreased. Among the 52 patients with reproductive desire, 39 successfully achieved pregnancy within 6 months of starting therapy (p = 0.001). Conclusions: Oral NAC improves endometriosis-related pain and the size of endometriomas. Furthermore, it decreases Ca125 serum levels and may improve fertility in patients with endometriosis.
format Online
Article
Text
id pubmed-10048621
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100486212023-03-29 Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes Anastasi, Emanuela Scaramuzzino, Sara Viscardi, Maria Federica Viggiani, Valentina Piccioni, Maria Grazia Cacciamani, Laura Merlino, Lucia Angeloni, Antonio Muzii, Ludovico Porpora, Maria Grazia Int J Environ Res Public Health Article Background: Endometriosis is a chronic, estrogen-dependent, inflammatory disease, whose pivotal symptoms are dysmenorrhea, dyspareunia, and chronic pelvic pain (CPP). Besides the usual medical treatments, recent evidence suggests there are potential benefits of oral N-acetylcysteine (NAC) on endometriotic lesions and pain. The primary objective of this prospective single-cohort study was to confirm the effectiveness of NAC in reducing endometriosis-related pain and the size of ovarian endometriomas. The secondary objective was to assess if NAC may play a role in improving fertility and reducing the Ca125 serum levels. Methods: Patients aged between 18–45 years old with a clinical/histological diagnosis of endometriosis and no current hormonal treatment or pregnancy were included in the study. All patients received quarterly oral NAC 600 mg, 3 tablets/day for 3 consecutive days of the week for 3 months. At baseline and after 3 months, dysmenorrhea, dyspareunia and CPP were assessed using the Visual Analog Scale score (VAS), while the size of the endometriomas was estimated through a transvaginal ultrasound. Analgesics (NSAIDs) intake, the serum levels of Ca125 and the desire for pregnancy were also investigated. Finally, the pregnancy rate of patients with reproductive desire was evaluated. Results: One hundred and twenty patients were recruited. The intensity of dysmenorrhea, dyspareunia and CPP significantly improved (p < 0.0001). The use of NSAIDs (p = 0.001), the size of the endometriomas (p < 0.0001) and the serum levels of Ca125 (p < 0.0001) significantly decreased. Among the 52 patients with reproductive desire, 39 successfully achieved pregnancy within 6 months of starting therapy (p = 0.001). Conclusions: Oral NAC improves endometriosis-related pain and the size of endometriomas. Furthermore, it decreases Ca125 serum levels and may improve fertility in patients with endometriosis. MDPI 2023-03-07 /pmc/articles/PMC10048621/ /pubmed/36981595 http://dx.doi.org/10.3390/ijerph20064686 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Anastasi, Emanuela
Scaramuzzino, Sara
Viscardi, Maria Federica
Viggiani, Valentina
Piccioni, Maria Grazia
Cacciamani, Laura
Merlino, Lucia
Angeloni, Antonio
Muzii, Ludovico
Porpora, Maria Grazia
Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes
title Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes
title_full Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes
title_fullStr Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes
title_full_unstemmed Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes
title_short Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes
title_sort efficacy of n-acetylcysteine on endometriosis-related pain, size reduction of ovarian endometriomas, and fertility outcomes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10048621/
https://www.ncbi.nlm.nih.gov/pubmed/36981595
http://dx.doi.org/10.3390/ijerph20064686
work_keys_str_mv AT anastasiemanuela efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes
AT scaramuzzinosara efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes
AT viscardimariafederica efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes
AT viggianivalentina efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes
AT piccionimariagrazia efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes
AT cacciamanilaura efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes
AT merlinolucia efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes
AT angeloniantonio efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes
AT muziiludovico efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes
AT porporamariagrazia efficacyofnacetylcysteineonendometriosisrelatedpainsizereductionofovarianendometriomasandfertilityoutcomes